Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Twist Bioscience's share price for the quarter that ended in Sep. 2024 was $45.18. Twist Bioscience's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 58.9 Mil. Therefore, Twist Bioscience's market cap for the quarter that ended in Sep. 2024 was $2,660.1 Mil.
Twist Bioscience's quarterly market cap
increased
from Mar. 2024 ($1,995.5 Mil) to Jun. 2024 ($2,883.8 Mil) but then
declined
from Jun. 2024 ($2,883.8 Mil) to Sep. 2024 ($2,660.1 Mil).
Twist Bioscience's annual market cap
declined
from Sep. 2022 ($1,991.9 Mil) to Sep. 2023 ($1,166.1 Mil) but then
increased
from Sep. 2023 ($1,166.1 Mil) to Sep. 2024 ($2,660.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Twist Bioscience's Enterprise Value for Today is $2,708.8 Mil.
Twist Bioscience Market Cap Historical Data
The historical data trend for Twist Bioscience's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Twist Bioscience's Market Cap
For the Diagnostics & Research subindustry, Twist Bioscience's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Twist Bioscience's Market Cap Distribution in the Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Twist Bioscience's Market Cap distribution charts can be found below:
* The bar in red indicates where Twist Bioscience's Market Cap falls into.
Twist Bioscience Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Twist Bioscience's Market Cap for the fiscal year that ended in Sep. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Twist Bioscience (NAS:TWST) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Twist Bioscience Market Cap Related Terms
Thank you for viewing the detailed overview of Twist Bioscience's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well-plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies and powers cost-effective, rapid high-throughput synthesis, enabling researchers to realize opportunities ahead rapidly. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TWST has been successfully added to your 